Entrectinib for the treatment of metastatic NSCLC: safety and efficacy.

作者: Andrea Sartore-Bianchi , Elio Gregory Pizzutilo , Giovanna Marrapese , Federica Tosi , Giulio Cerea

DOI: 10.1080/14737140.2020.1747439

关键词:

摘要: Introduction: Gene fusions are strong driver alterations in various cancers, increasingly diagnosed with multiple testing techniques. ROS1 can be found 1-2% of non-small cell lung cancer...

参考文章(58)
Alice Tsang Shaw, D Ross Camidge, Jeffrey A. Engelman, Benjamin J. Solomon, Eunice Lee Kwak, Jeffrey W. Clark, Ravi Salgia, Geoffrey Shapiro, Yung-Jue Bang, Weiwei Tan, Lesley Tye, Keith D. Wilner, Patricia Stephenson, Marileila Varella-Garcia, Kristin Bergethon, A. John Iafrate, Sai-Hong Ignatius Ou, Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement. Journal of Clinical Oncology. ,vol. 30, pp. 7508- 7508 ,(2012) , 10.1200/JCO.2012.30.15_SUPPL.7508
Doron Lipson, Philip J Stephens, Vince A Miller, Marileila Varella-Garcia, Pasi A Jänne, Robert C Doebele, Aria Vaishnavi, Marzia Capelletti, Anh T Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D Davies, Dara L Aisner, Amanda B Pilling, Eamon M Berge, Jhingook Kim, Hidefumi Sasaki, Seung-il Park, Gregory Kryukov, Levi A Garraway, Peter S Hammerman, Julia Haas, Steven W Andrews, Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nature Medicine. ,vol. 19, pp. 1469- 1472 ,(2013) , 10.1038/NM.3352
Alice T. Shaw, Sai-Hong I. Ou, Yung-Jue Bang, D. Ross Camidge, Benjamin J. Solomon, Ravi Salgia, Gregory J. Riely, Marileila Varella-Garcia, Geoffrey I. Shapiro, Daniel B. Costa, Robert C. Doebele, Long Phi Le, Zongli Zheng, Weiwei Tan, Patricia Stephenson, S. Martin Shreeve, Lesley M. Tye, James G. Christensen, Keith D. Wilner, Jeffrey W. Clark, A. John Iafrate, Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 371, pp. 1963- 1971 ,(2014) , 10.1056/NEJMOA1406766
Jaime Acquaviva, Ricky Wong, Al Charest, None, The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochimica et Biophysica Acta. ,vol. 1795, pp. 37- 52 ,(2009) , 10.1016/J.BBCAN.2008.07.006
Helen Y. Zou, Qiuhua Li, Lars D. Engstrom, Melissa West, Vicky Appleman, Katy A. Wong, Michele McTigue, Ya-Li Deng, Wei Liu, Alexei Brooun, Sergei Timofeevski, Scott R. P. McDonnell, Ping Jiang, Matthew D. Falk, Patrick B. Lappin, Timothy Affolter, Tim Nichols, Wenyue Hu, Justine Lam, Ted W. Johnson, Tod Smeal, Al Charest, Valeria R. Fantin, PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 3493- 3498 ,(2015) , 10.1073/PNAS.1420785112
Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella-Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles Rudin, Joan Schiller, Eric B. Haura, Mark Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn, Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs JAMA. ,vol. 311, pp. 1998- 2006 ,(2014) , 10.1001/JAMA.2014.3741
Ying Liang, Heather A. Wakelee, Joel W. Neal, Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung Cancer. Clinical Lung Cancer. ,vol. 16, pp. 366- 373 ,(2015) , 10.1016/J.CLLC.2014.12.009
Robert C. Doebele, Amanda B. Pilling, Dara L. Aisner, Tatiana G. Kutateladze, Anh T. Le, Andrew J. Weickhardt, Kimi L. Kondo, Derek J. Linderman, Lynn E. Heasley, Wilbur A. Franklin, Marileila Varella-Garcia, D. Ross Camidge, Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer Clinical Cancer Research. ,vol. 18, pp. 1472- 1482 ,(2012) , 10.1158/1078-0432.CCR-11-2906
Benjamin J Solomon, Tony Mok, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari, Shrividya Iyer, Arlene Reisman, Keith D Wilner, Jennifer Tursi, Fiona Blackhall, None, First-line crizotinib versus chemotherapy in ALK-positive lung cancer The New England Journal of Medicine. ,vol. 371, pp. 2167- 2177 ,(2014) , 10.1056/NEJMOA1408440
Kristin Bergethon, Alice T. Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M. Lovly, Nerina T. McDonald, Pierre P. Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang, Eugene J. Mark, Julie M. Batten, Haiquan Chen, Keith D. Wilner, Eunice L. Kwak, Jeffrey W. Clark, David P. Carbone, Hongbin Ji, Jeffrey A. Engelman, Mari Mino-Kenudson, William Pao, A. John Iafrate, ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers Journal of Clinical Oncology. ,vol. 30, pp. 863- 870 ,(2012) , 10.1200/JCO.2011.35.6345